Biomarkers are nowadays widely used to expedite the drug discovery process. This is done by using biomarker change as the end point of the treatment instead of measuring the visible physical change of the target person. Drug discovery which requires research and documentation for decades together could be reduced to few years with the use of Biomarkers.

In INGENIZ, the rich talent pool of people we have with 14+ years of experience are experts in identifying and classifying the Biomarkers. The same experts can also tell you the use of the biomarkers. With this knowledge you can create a database of biomarkers which could be useful in predicting or following up with the treatment.